SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-13-000477
Filing Date
2013-08-07
Accepted
2013-08-07 16:29:47
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED 6/30/2013 appy_10q-063013.htm 10-Q 752520
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 11741
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 11832
4 EXHIBIT 32 ex32.htm EX-32 9677
  Complete submission text file 0001079973-13-000477.txt   6992406

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE appy-20130630.xml EX-101.INS 704430
6 XBRL SCHEMA FILE appy-20130630.xsd EX-101.SCH 41274
7 XBRL CALCULATION FILE appy-20130630_cal.xml EX-101.CAL 35417
8 XBRL DEFINITION FILE appy-20130630_def.xml EX-101.DEF 157099
9 XBRL LABEL FILE appy-20130630_lab.xml EX-101.LAB 542134
10 XBRL PRESENTATION FILE appy-20130630_pre.xml EX-101.PRE 258456
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 131017964
SIC: 2835 In Vitro & In Vivo Diagnostic Substances